Bioverge
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO
Geographical Focus
United States
Industries Focus
- Healthcare
- Life Sciences
- Healthcare Services
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Health and Wellness
- Healthcare Technology
- Medical Research
- Medical Equipment
- Health Insurance
- Healthcare Consulting
- Health IT
Investment Size:
5,000 to 500,000 USD
Investor Details Founded: 2016
Bioverge is an investment platform specializing in innovative healthcare startups. Their highly curated investment opportunities include emerging healthcare companies, operating at the convergence of biology and technology. Founded in 2016, it is an investment platform that funds visionary entrepreneurs with the aim of transforming healthcare and bringing science fiction to life.
Bioverge offers a unique opportunity for investors. Investing once means that, as a shareholder, you’ll benefit financially from every investment they make, and every fund they manage. Their syndication model aggregates accredited investors into a Special Purpose Vehicle (SPV), which then invests directly in a single company or in multiple companies through one of their Access Funds or Thematic Funds.
Bioverge has built a portfolio of 29 companies and has participated in 11 follow-on rounds for its portfolio companies, many of which are supported by some of the world's top-performing venture capital firms. Key among the company's offerings is access to the Bioverge Network, a consortium of functional specialists capable of supporting scientific and technical founders alongside experts to source and conduct diligence on new investment opportunities.
Requirements
- Accredited investors
- Compliance with SEC's Regulation D, Rule 506
- Adherence to regulations of respective jurisdictions
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Alto Neuroscience
- Aspen Neuroscience
- Bionaut Labs
- Contraline
- CrowdMed
- Elucid
- Enveda Biosciences
- HepaTx
- Leucadia Therapeutics
- Notable Labs
- OccamzRazor
- Ochre Bio
Mentioned In
-
$24.95
-
$24.95
-
$19.95
-
$49.95
-
$14.95
-
$39.95
-
$299.00
Claim this Investor
Are you an official representative of Bioverge?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim